Article
July 1, 2026
By Jacob Porpossian
Health and Pharma showed up differently this year at Cannes Lions 2026. What we witnessed solidified the trend we’ve been seeing over the last 18 months. The most effective work stopped treating science and culture as opposing forces. In fact, when bridged together, is when the work became the strongest.
From the Super Bowl to the Oscars, and now across the Cannes shortlist, the winning campaigns recognized that patients are more than just consumers of medical information. They’re participants in culture. In an industry all-too familiar with regulation, the increased political, social, and economic uncertainty of recent years has added even more barriers to getting bold creative work out into the world. Legal teams are more cautious. Approval processes have lengthened. But here’s what’s critical: the brands moving fastest aren’t waiting for permission to ease. They’re leveraging culture as a bridge between science and human behavior.
Relax Your Tight End didn’t win the Grand Prix because of a clever concept.
Novartis won because the brand identified a cultural barrier. It took hold of the shame and misconceptions around male health screening and addressed it through an institution men trusted: the NFL. The culmination of football heroes and personalities speaking openly about prostate cancer, a Super Bowl platform, real-world testing at games and the discovery through a cultural moment that already mattered created the perfect campaign to follow up last year’s focus on breast cancer with “Your Attention Please” and the ultimate multi-year strategy to solidify Novartis as a brand to remember and trust when thinking oncology.
That same human truth showed up across this year’s other finalists. For example, Beat Cancer Off wasn’t afraid to say what everyone was thinking. The campaign leaned into a human truth about male sexuality and early cancer prevention, encouraging men to embrace a natural behavior as part of preventative health. And once again, Viagra found a way to work within China’s regulatory constraints by embracing creative mischief.
For healthcare organizations moving forward, here’s what we can learn from our time at the Palais.
1. Reframe uncertainty as opportunity. Political and social turbulence requires strategic boldness, not retreat.
2. Lead with cultural insight. The winning work didn’t lead with efficacy data. It started with a human barrier and found a cultural entry point.
3. Build for tentpole moments. Combine broadcast with real-world activation, executive voice with earned conversation.
4. Partner across both worlds. You need creative ambition married to regulatory rigor.
The conversation has shifted from science or culture to science and culture. The question now is whether your organization is ready to move.
Jacob Porpossian is the Global Executive Creative Director for FleishmanHillard’s Health & Life Sciences practice, where he builds and leads creative and storytelling capabilities for major health brands. With a background spanning creative strategy, digital marketing, communications, and production, he advises integrated teams across healthcare, CPG, corporate, and technology sectors, while also championing diversity and inclusion initiatives across the agency and industry.
See what else is happening
You might also like
-
Expertise
The Visible CEO: How Leadership Can Serve as a Strategic Asset
July 1, 2026
-
Expertise
How to Win the GLP-1 Food Industry Wake-Up Call
June 30, 2026
-
Expertise
Cannes Lions Exposed an Industry’s Transition of Power: Takeaways From Winning Work
June 26, 2026
-
Expertise
Lessons From Cannes: Don’t Let Speed Fail Storytelling
June 25, 2026
-
Expertise
Get Bold Work Out Into the World: How to Seize the Chaos Advantage
June 25, 2026
-
Expertise
The Action Gap: Leaders Know Bold Work Wins. They’re Just Not Moving Fast Enough.
June 23, 2026
-
Expertise
From Storytellers to Strategic Advisors: Sports Leaders Provide Valuable Lessons for Communicators
June 23, 2026
-
Expertise
The AI Readiness Gap Series: How to Build a Culture of Experimentation
June 22, 2026
-
Expertise
Introducing The Chaos Advantage: Why Playing It Safe Is the Riskiest Move
June 22, 2026
